These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30392335)

  • 21. Population impact of HPV vaccines: summary of early evidence.
    Hariri S; Markowitz LE; Dunne EF; Unger ER
    J Adolesc Health; 2013 Dec; 53(6):679-82. PubMed ID: 24263069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The vaccines anti-HPV today in the treatment of the genital infections to HPV].
    Gondry J
    Ann Dermatol Venereol; 2017 Dec; 144(12S):S9-S10. PubMed ID: 29108875
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
    Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
    Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing the power of prevention: human papillomavirus vaccines.
    Mayeaux EJ
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
    BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
    Licht AS; Murphy JM; Hyland AJ; Fix BV; Hawk LW; Mahoney MC
    Sex Transm Infect; 2010 Feb; 86(1):74-8. PubMed ID: 19841004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis.
    Lukács A; Máté Z; Farkas N; Mikó A; Tenk J; Hegyi P; Németh B; Czumbel LM; Wuttapon S; Kiss I; Gyöngyi Z; Varga G; Rumbus Z; Szabó A
    BMC Public Health; 2020 May; 20(1):691. PubMed ID: 32460747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the new HPV vaccines in clinical practice.
    Widdice LE; Kahn JA
    Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the Human Papillomavirus Vaccination in Management of HPV-associated Cutaneous Lesions.
    Gay J; Johnson N; Kavuru V; Phillips M
    Skin Therapy Lett; 2021 Mar; 26(2):6-8. PubMed ID: 33769773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HPV vaccination with quadrivalent or nonavalent vaccine: an opportunity to eliminate genital warts as well].
    van Bergen JEAM
    Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32073799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Age for HPV vaccination: recommandations from the French high council of public health].
    Heard I; Floret D
    Med Sci (Paris); 2013 Dec; 29(12):1161-6. PubMed ID: 24356148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing cervical cancer and genital warts - How much protection is enough for HPV vaccines?
    Stanley M
    J Infect; 2016 Jul; 72 Suppl():S23-8. PubMed ID: 27211079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HPV prophylactic vaccines].
    Konopnicki D
    Rev Med Brux; 2014 Sep; 35(4):338-42. PubMed ID: 25675641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.